The EPS projection of Imax Corporation (NYSE:IMAX) for quarter ended 2016-09-30 is $0.16. Last week, the EPS forecast was $0.16 against target of $0.16, a month earlier. Two months ago, this estimate was $0.16 versus forecast of $0.16 three months earlier, implying a deviation of 0%.
Imax Corporation (NYSE:IMAX) stated that 18 days ago, its stock price was positively revised 1 times while negative revisions were 2.
In last week, the experts lowered EPS 0 times and increased EPS 0 times. In last 30, 120, 60 and 90 days, the experts upped revisions 0 , 1, 0, and 0, correspondingly.
EPS estimate downgrade for Imax Corporation (NYSE:IMAX) in the preceding 30, 120, 60 and 90 days were 1, 2, 2, and 4, correspondingly.
Imax Corporation (NYSE:IMAX) EPS target for the quarter closed 1 was $0.16, based on 4 recommendations. As reported on 2016-04-21 the EPS was $0.14. The change was $0.05, implying a percentage deviation of 55.56%. The projections showed a standard deviation of 0.02.
Quarterly Sales Estimates
Imax Corporation (NYSE:IMAX) yearly sales prediction for the fiscal 2017 stands at $134.034 and the median estimate is at $136.181. Almost 4 analysts issued sales target.
Highest sales target is $141.775 while the lowest target is $122 showing standard deviation of 8.879%.
As many as 4 analysts have sales targets revised upside while 4 reduced sales estimates, implying a deviation of 0%.
Last month, 4 revised sales number projection on upside while 4 lowered the sales projections, implying a deviation of 1.905%.
A quarter ago, 4 hiked sales target and 4 reduced sales forecast. Imax Corporation (NYSE:IMAX) announced that the deviation in forecast was 6.486%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...